102 results
Page 2 of 6
S-8
EX-99.3
eq8j12cc3k78p1swafx7
14 Jan 22
Registration of securities for employees
5:04pm
8-K
EX-99.2
5zauf
15 Nov 21
Regulation FD Disclosure
11:32am
424B5
dhzd3q89syi2ykkh98
12 Nov 21
Prospectus supplement for primary offering
4:09pm
8-K
d53em hss
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
8-K
EX-99.1
5y2r6s88i 2dqtiqr
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
8-K
EX-1.1
wyir7e7uqxx7oguzb
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
424B5
8ouxu60p0aoqcrxi6l
19 Mar 21
Prospectus supplement for primary offering
4:04pm
424B5
8nee2sj6q4oxfujm71
17 Mar 21
Prospectus supplement for primary offering
5:07pm
8-K
2hlce9t2e0wt5ei0mcv
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am